Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Stock Gets Price Target Increase from Barclays

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) had its price objective lifted by equities research analysts at Barclays from $10.00 to $11.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s price objective suggests a potential downside of 14.22% from the company’s current price.

Several other equities analysts have also recently issued reports on the company. HC Wainwright reaffirmed a “buy” rating and issued a $14.00 price objective on shares of Senseonics Holdings, Inc. Common Stock in a research report on Tuesday. Stifel Nicolaus reiterated a “hold” rating and set a $10.00 target price (up from $9.00) on shares of Senseonics Holdings, Inc. Common Stock in a research report on Tuesday. Weiss Ratings upgraded shares of Senseonics Holdings, Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, November 4th. Mizuho reduced their target price on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating for the company in a research note on Wednesday, July 15th. Finally, Wall Street Zen upgraded Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Three analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $13.60.

Senseonics Holdings, Inc. Common Stock Stock Performance

NASDAQ SENS opened at $12.82 on Tuesday. The company has a current ratio of 6.74, a quick ratio of 6.40 and a debt-to-equity ratio of 0.62. The company has a fifty day simple moving average of $9.12 and a 200 day simple moving average of $7.26. The company has a market cap of $536.00 million, a P/E ratio of -5.79 and a beta of 1.04. Senseonics Holdings, Inc. Common Stock has a 12-month low of $4.79 and a 12-month high of $13.88.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last issued its quarterly earnings results on Monday, November 9th. The company reported ($0.50) EPS for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.01). The firm had revenue of $19.56 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. Sell-side analysts predict that Senseonics Holdings, Inc. Common Stock will post -2.31 earnings per share for the current fiscal year.

Insider Activity at Senseonics Holdings, Inc. Common Stock

In other Senseonics Holdings, Inc. Common Stock news, Director Douglas Roeder acquired 13,953 shares of the company’s stock in a transaction dated Wednesday, August 19th. The stock was bought at an average price of $8.98 per share, with a total value of $125,297.94. Following the completion of the transaction, the director directly owned 171,191 shares of the company’s stock, valued at approximately $1,537,295.18. The trade was a 8.87% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 4.70% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock

Institutional investors and hedge funds have recently bought and sold shares of the stock. StoneX Group Inc. acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 3rd quarter valued at $128,000. Traynor Capital Management Inc. bought a new position in Senseonics Holdings, Inc. Common Stock in the 3rd quarter valued at $152,000. State of Wyoming grew its stake in shares of Senseonics Holdings, Inc. Common Stock by 27.2% during the third quarter. State of Wyoming now owns 14,940 shares of the company’s stock worth $152,000 after purchasing an additional 3,199 shares during the period. Integrated Wealth Concepts LLC acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock during the second quarter worth about $36,000. Finally, Readystate Asset Management LP bought a new position in shares of Senseonics Holdings, Inc. Common Stock during the second quarter worth about $574,000. Institutional investors own 12.36% of the company’s stock.

Senseonics Holdings, Inc. Common Stock News Summary

Here are the key news stories impacting Senseonics Holdings, Inc. Common Stock this week:

• Positive Sentiment: Senseonics raised its FY 2026 revenue guidance to $68 million–$70 million, up from $62 million–$66 million and above the $64.2 million consensus estimate. It also lifted its full-year gross-margin outlook to more than 60%. Third-quarter 2026 results
• Positive Sentiment: Third-quarter revenue was about $19.6 million, up approximately 140% year over year, and exceeded analyst revenue estimates, highlighting strong sales growth. Q3 results and revenue estimates
• Positive Sentiment: HC Wainwright reaffirmed its Buy rating and set a $14 price target. Raymond James also upgraded SENS, moving its rating from Underperform to Market Perform. HC Wainwright rating
• Negative Sentiment: The company reported a third-quarter loss of $0.50 per share, slightly worse than the $0.49 consensus loss and wider than the $0.43 loss a year earlier. Quarterly earnings results

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application.

The company’s primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.